TY - JOUR
T1 - Perioperative Morbidity of Lymph Node Dissection for Renal Cell Carcinoma
T2 - A Propensity Score-based Analysis
AU - Gershman, Boris
AU - Moreira, Daniel M.
AU - Thompson, R. Houston
AU - Boorjian, Stephen A.
AU - Lohse, Christine M.
AU - Costello, Brian
AU - Cheville, John C.
AU - Leibovich, Bradley C.
PY - 2017/1/1
Y1 - 2017/1/1
N2 - Background: There are little data regarding the morbidity of lymph node dissection (LND) for renal cell carcinoma (RCC) to assess its risk-benefit ratio. Objective: To evaluate the association of LND with 30-d complications among patients undergoing radical nephrectomy (RN) for RCC. Design, setting, and participants: A total of 2066 patients underwent RN for M0 or M1 RCC between 1990 and 2010, of whom 774 (37%) underwent LND. Intervention: RN with or without LND. Outcome measurements and statistical analysis: Associations of LND with 30-d complications were examined using logistic regression with several propensity score techniques. Extended LND, defined as removal of ≥13 lymph nodes, was examined in a sensitivity analysis. Results and limitations: A total of 184 (9%) patients were pN1 and 302 (15%) were M1. Thirty-day complications occurred in 194 (9%) patients, including Clavien grade ≥3 complications in 81 (4%) patients. Clinicopathologic features were well balanced after propensity score adjustment. In the overall cohort, LND was not statistically significantly associated with Clavien grade ≥3 complications, although there was an approximately 40% increased risk of any Clavien grade complication that did not reach statistical significance. Likewise, LND was not significantly associated with any Clavien grade or Clavien grade ≥3 complications when separately evaluated among M0 or M1 patients. Extended LND was not significantly associated with any Clavien grade or Clavien grade ≥3 complications. LND was not associated with length of stay or estimated blood loss. Limitations include a retrospective design. Conclusions: LND is not significantly associated with an increased risk of Clavien grade ≥3 complications, although it may be associated with a modestly increased risk of minor complications. In the absence of increased morbidity, LND may be justified in a predominantly staging role in the management of RCC. Patient summary: Lymph node dissection for renal cell carcinoma is not associated with increased rates of major complications. Lymph node dissection for renal cell carcinoma is not associated with increased rates of major complications among patients undergoing radical nephrectomy.
AB - Background: There are little data regarding the morbidity of lymph node dissection (LND) for renal cell carcinoma (RCC) to assess its risk-benefit ratio. Objective: To evaluate the association of LND with 30-d complications among patients undergoing radical nephrectomy (RN) for RCC. Design, setting, and participants: A total of 2066 patients underwent RN for M0 or M1 RCC between 1990 and 2010, of whom 774 (37%) underwent LND. Intervention: RN with or without LND. Outcome measurements and statistical analysis: Associations of LND with 30-d complications were examined using logistic regression with several propensity score techniques. Extended LND, defined as removal of ≥13 lymph nodes, was examined in a sensitivity analysis. Results and limitations: A total of 184 (9%) patients were pN1 and 302 (15%) were M1. Thirty-day complications occurred in 194 (9%) patients, including Clavien grade ≥3 complications in 81 (4%) patients. Clinicopathologic features were well balanced after propensity score adjustment. In the overall cohort, LND was not statistically significantly associated with Clavien grade ≥3 complications, although there was an approximately 40% increased risk of any Clavien grade complication that did not reach statistical significance. Likewise, LND was not significantly associated with any Clavien grade or Clavien grade ≥3 complications when separately evaluated among M0 or M1 patients. Extended LND was not significantly associated with any Clavien grade or Clavien grade ≥3 complications. LND was not associated with length of stay or estimated blood loss. Limitations include a retrospective design. Conclusions: LND is not significantly associated with an increased risk of Clavien grade ≥3 complications, although it may be associated with a modestly increased risk of minor complications. In the absence of increased morbidity, LND may be justified in a predominantly staging role in the management of RCC. Patient summary: Lymph node dissection for renal cell carcinoma is not associated with increased rates of major complications. Lymph node dissection for renal cell carcinoma is not associated with increased rates of major complications among patients undergoing radical nephrectomy.
KW - Complications
KW - Lymph node dissection
KW - Nephrectomy
KW - Propensity score
KW - Renal cell carcinoma
UR - http://www.scopus.com/inward/record.url?scp=85033603911&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85033603911&partnerID=8YFLogxK
U2 - 10.1016/j.eururo.2017.10.020
DO - 10.1016/j.eururo.2017.10.020
M3 - Article
C2 - 29132713
AN - SCOPUS:85033603911
SN - 0302-2838
JO - European Urology
JF - European Urology
ER -